PB0520 Atorvastatin Treatment Inhibits the Procoagulant Properties of a 3D Culture Model of the Human Neointimal Layer

ISTH Academy, Faculty / Presenters, 406534

PB0524 Preparation and Characterization of Nanocarriers for Transdermal Delivery of Enoxaparin

ISTH Academy, Faculty / Presenters, 406533

PB0043 Hypercoagulable State and Mortality in ICU Patients during 2020–2022: A Single Centre Report

ISTH Academy, Faculty / Presenters, 406520

PB0523 Effect of Flow on Structural and Mechanical Properties of the Fibrin Network in Plasma Thrombi

ISTH Academy, Faculty / Presenters, 406532

PB0026 Low Platelet Count has a Strong Worsening Impact on Outcome in Patients with Acute Coronary Syndromes: From the START Antiplatelet Registry

ISTH Academy, Faculty / Presenters, 406519

PB0028 The Impact of Cannulation Site on Bleeding and Thrombotic Outcomes in Venovenous ECMO

ISTH Academy, Faculty / Presenters, 406518

PB0027 Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians

ISTH Academy, Faculty / Presenters, 406517

PB0029 Bridging Therapy and Risk of Major Bleeding and Thrombosis with Continuous-Flow Left Ventricular Assist Device: A Quasi-Experimental Study

ISTH Academy, Faculty / Presenters, 406516

PB0031 Natural Antibodies to Oxidation-Specific Epitopes Characterize Hemodialysis Patients Protected from Cardiovascular Events

ISTH Academy, Faculty / Presenters, 406515

PB0032 Interpaly of Oxidative Stress Markers with Thrombo-Inflammatory Barkers in End Stage Renal Disease

ISTH Academy, Faculty / Presenters, 406514

PB0030 The Association between Depressive Symptom Profiles and Hemostasis: The Biobehavioral Pathway to Cardiovascular Diseases?

ISTH Academy, Faculty / Presenters, 406513

PB0034 Endogenous Dysregulation of Biomarkers of Thromboinflammatory Responses in End-Stage Renal Disease, and Their Amplification by Heart Failure

ISTH Academy, Faculty / Presenters, 406512

PB0033 Validated in vivo Model to Assess Direct Oral Anticoagulant Reversal Agents

ISTH Academy, Faculty / Presenters, 406511

PB0035 Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-Coated Aspirin in Patients with StablE Diabetes: Preliminary Findings from the APPEASED Study

ISTH Academy, Faculty / Presenters, 406510

PB0010 Neutrophil-Activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation on Anticoagulation

ISTH Academy, Faculty / Presenters, 406509

PB0012 Anticoagulant use and Prognosis of Non-Valvular Atrial Fibrillation Patients According to Baseline CHA2DS2-VASc Score and HAS-BLED Score

ISTH Academy, Faculty / Presenters, 406508

PB0011 Evaluation of the Association between Clinical Events and Apixaban/ Rivaroxaban’s Plasma exposure in Patients from the OptimAT Study

ISTH Academy, Faculty / Presenters, 406507

PB0014 Do Antiphospholipid Antibodies Inform the Choice of Anticoagulant Agents in Patients with Atrial Fibrillation?

ISTH Academy, Faculty / Presenters, 406506

PB0015 Potential of Racial Bias in Atrial Fibrillation Patients that are Switched from Warfarin to a Direct Oral Anticoagulant

ISTH Academy, Faculty / Presenters, 406505

PB0016 Plasma Protein Carbonylation is Associated with Unfavorably Altered Fibrin Clot Properties in Patients with Atrial Fibrillation: A Novel Risk Factor of Ischemic Cerebrovascular Events

ISTH Academy, Faculty / Presenters, 406504

PB0018 Direct Oral Anticoagulant Plasma Levels in Patients with Low Body Weight: A Retrospective Study

ISTH Academy, Faculty / Presenters, 406503

PB0021 Clinical Outcomes of Direct Oral Anticoagulants in Patients with Concomitant Use of Antiepileptic Drugs in the Real-World Registry MACACOD

ISTH Academy, Faculty / Presenters, 406502

PB0020 Anticoagulation Discharge Treatment Recommendations in Patients Admitted with a First-Time Diagnosis of Atrial Fibrillation

ISTH Academy, Faculty / Presenters, 406501

PB0019 Direct Oral Anticoagulants and Risk of Kidney Disease

ISTH Academy, Faculty / Presenters, 406500

PB0023 Oral Anticoagulants in Patients with Atrial Fibrillation and Comorbid Conditions

ISTH Academy, Faculty / Presenters, 406499

PB0022 Impact of COVID-19 on Thromboembolic Events and Mortality among Patients with Non-Valvular Atrial Fibrillation Receiving Oral Anticoagulants

ISTH Academy, Faculty / Presenters, 406498

PB0024 Left Atrial Appendage Closure (LAAC) as an Alternative to Oral Anticoagulation (OACs) in Patients with Atrial Fibrillation (AF): A Single Centre Experience

ISTH Academy, Faculty / Presenters, 406497

PB0025 Collagen Remodeling, Inflammatory Biomarkers and Fatty Acid Regulation in Understanding the Molecular Pathogenesis of Atrial Fibrillation

ISTH Academy, Faculty / Presenters, 406496

PB0006 Investigation of the Antiplatelet, Antioxidant and Anti-Inflammatory Potency of Berries Extracts

ISTH Academy, Faculty / Presenters, 406495

PB0008 Increased Levels of Plasma Cell-Free DNA are Associated with Symptomatology in Patients with Carotid Stenosis and are Independent of Plasma DNaseI Activity

ISTH Academy, Faculty / Presenters, 406494

PB0001 Force Balance Ratio is a Robust Predictor of Arterial Thrombus Embolization

ISTH Academy, Faculty / Presenters, 406493

PB0003 Clinical Outcomes and Associated Factors in Patients who Underwent Successful Percutaneous Coronary Intervention: A 5-Year Multicenter Retrospective Study from a Developing Country

ISTH Academy, Faculty / Presenters, 406492

PB0002 Transient New-Onset Atrial Fibrillation is Associated with Poor Clinical Outcomes in Patients with Acute Myocardial Infarction

ISTH Academy, Faculty / Presenters, 406491

PB0005 The Interest of the Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratio in the Prediction of Thrombus in Myocardial Infarction

ISTH Academy, Faculty / Presenters, 406490

PB0004 A Case of Bivalirudin Associated Diffuse Alveolar Hemorrhage following Percutaneous Coronary Intervention

ISTH Academy, Faculty / Presenters, 406489

PB0039 Long Term Follow-Up of Cerebral Magnetic Resonance Imaging in Patients with Antiphospholipid Syndrome Assessing the Risk Factors for Recurrent Cerebral Events

ISTH Academy, Faculty / Presenters, 406521

PB0041 Prevalence of Vascular Risk Factors and I/D Angiotensin-Converting Enzyme Gene (ACE) Polymorphism in Costa Rican Elderly Patients with Cognitive Impariment

ISTH Academy, Faculty / Presenters, 406522

PB0040 Assessing Inter-Operator Variability in Gating Strategy of Whole Blood Monocyte Subsets Using Flow Cytometry in Patients with Acute Stroke Suspicion

ISTH Academy, Faculty / Presenters, 406523

PB0037 Thrombotic Cerebrovascular Outcomes in Patients with Fibromuscular Dysplasia Treated with Antiplatelet Agents or Anticoagulants: A Single-Center Experience

ISTH Academy, Faculty / Presenters, 406524

PB0036 Plasma Protein Carbonyl Levels Contribute to Prothrombotic Fibrin Clot Phenotype in Acute Ischemic Stroke Patients: Associations with Clinical Outcomes

ISTH Academy, Faculty / Presenters, 406525

PB0045 SEM and 3D Reconstruction of ex-vivo Arterial Thrombi: A Pilot Study

ISTH Academy, Faculty / Presenters, 406526

PB0044 Pediatric Arterial Thrombosis: Patient Characteristics and Thrombosis Outcomes

ISTH Academy, Faculty / Presenters, 406527

PB0529 Haemostatic Properties of Chromolaena Odorata: Evaluation of in vivo and in vitro Activity

ISTH Academy, Faculty / Presenters, 406528

PB0522 Characterization of Coagulopathy in a Swine Muscle Injury Model

ISTH Academy, Faculty / Presenters, 406531

PB0525 Identification of an Aberrant Cell Population in a Knock-in Murine Model with RUNX1 Variant Generated by CRISPR/Cas9

ISTH Academy, Faculty / Presenters, 406530

PB0527 Assessment of the Rats Model of Hemophilic Arthritis by Micro CT Scanning

ISTH Academy, Faculty / Presenters, 406529

SSC on the Case: Perioperative and Critical Care: Defining Heparin Resistance: What Clinicians Need to Know

ISTH Academy, Faculty / Presenters, 400200

“MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism?”: reply

ISTH Academy, Jeroen Buijs, 400587

“MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism?”: comment

ISTH Academy, Sven Danckwardt, 400586

The ISTH SSC subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration: reply

ISTH Academy, Faculty / Presenters, 400585

“The ISTH SSC subcommittee on hemostatic management of patients with liver disease: goals, ambitions, and call for collaboration”: comment

ISTH Academy, Faculty / Presenters, 400584

Congenital factor XI deficiency and risk of heart failure in humans

ISTH Academy, María Eugenia de la Morena-Barrio, 400583

C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization study

ISTH Academy, Faculty / Presenters, 400582

Should we consider gene therapy in severe inherited thrombophilia? Communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia

ISTH Academy, Faculty / Presenters, 400581

Results of an international survey about methods used to isolate human endothelial colony-forming cells: guidance from the SSC on Vascular Biology of the ISTH

ISTH Academy, David Smadja, 400580

Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology

ISTH Academy, Faculty / Presenters, 400579

Sex-specific association between microvascular health and coagulation parameters: the Netherlands Epidemiology of Obesity study

ISTH Academy, Bernard M. van den Berg, 400578

NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel

ISTH Academy, Kimberly Martinod, 400577

Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study

ISTH Academy, Michael Nagler, 400576

Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation

ISTH Academy, , 400575

Single-cell analysis of megakaryopoiesis in peripheral CD34 cells: insights into ETV6-related thrombocytopenia

ISTH Academy, Marjorie Poggi, 400574

Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis

ISTH Academy, Andreas Greinacher, 400573

Anti–β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C

ISTH Academy, Rolf Urbanus, 400572

Anticoagulant treatment for pediatric splanchnic vein thrombosis: a systematic review and meta-analysis

ISTH Academy, Sarina Levy-Mendelovich, 400571

Bioactive surface coating for preventing mechanical heart valve thrombosis

ISTH Academy, Cécile Oury, 400570

Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation

ISTH Academy, , 400569

S. Paul Bajaj (1944-2022)

ISTH Academy, Sriram Krishnaswamy, 400588

Plasma levels of P-selectin and future risk of incident venous thromboembolism

ISTH Academy, Faculty / Presenters, 400567

Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children’s Hospital Acquired Thrombosis consortium

ISTH Academy, Faculty / Presenters, 400566

Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure

ISTH Academy, James Luyendyk, 400565

Activation of Piezo1 channels in compressed red blood cells augments platelet-driven contraction of blood clots

ISTH Academy, John Weisel, 400564

Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy

ISTH Academy, Sebastien Lacroix-Desmazes, 400563

Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII–deficient mice after induced hemarthrosis

ISTH Academy, Annette von Drygalski, 400562

Structures of factor XI and prekallikrein bound to domain 6 of high–molecular weight kininogen reveal alternate domain 6 conformations and exosites

ISTH Academy, Jonas Emsley, 400561

A commentary on “maladaptive lymphangiogenesis” according to Newton’s third law: the law of action and reaction as it applies to joint bleeding

ISTH Academy, Leonard Valentino, 400560

Kids! We need to CHAT about clots and central lines

ISTH Academy, Faculty / Presenters, 400559

Kininogen debuts on apple (domain) disks

ISTH Academy, David Gailani, 400558

Translate or differentiate? Molecular mechanisms of ETV6-related thrombocytopenia

ISTH Academy, Virginia Camacho, 400557

Commentary on “Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure”

ISTH Academy, Hunter Moore, 400556

Poised to cast wide NETs in long COVID

ISTH Academy, , 400555

Hemophilia gene therapy: first, do no harm

ISTH Academy, Faculty / Presenters, 400554

Why platelet mechanotransduction matters for hemostasis and thrombosis

ISTH Academy, Wilbur Lam, 400553

Novel vascular roles of human endoglin in pathophysiology

ISTH Academy, Faculty / Presenters, 400552

Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood

ISTH Academy, Faculty / Presenters, 400551

Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022

ISTH Academy, Faculty / Presenters, 400550

Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study

ISTH Academy, Cihan Ay, 400568

Hemostasis in Trauma and Critical Illness

ISTH Academy, Faculty / Presenters, 393955

Takeda on ISTH Academy

ISTH Academy, Faculty / Presenters, 400351

HTRS2023.P2.3 F8 variants in women and girls evaluated for hemophilia A

ISTH Academy, Faculty / Presenters, 401399

HTRS2023.P2.2 Mim8 clinical development program: an overview of FRONTIER studies with results from a multiple ascending dose study of Mim8 in patients with severe hemophilia A with or without factor VIII inhibitors

ISTH Academy, Faculty / Presenters, 401398

HTRS2023.P2.5 Joint surveillance with ultrasound in pediatric hemophilia A patients on emicizumab: a single institution retrospective review

ISTH Academy, Faculty / Presenters, 401400

HTRS2023.P1.6 Characterization and expression of atypical type 2B variants in the Zimmerman Program

ISTH Academy, Faculty / Presenters, 401396

HTRS2023.P1.5 Macrothrombocytopenia, significantly elevated IPF, and severe epistaxis mistaken for ITP: a case report of GNE-related thrombocytopenia

ISTH Academy, Faculty / Presenters, 401395

HTRS2023.P1.4 Characterization of the binding interaction between factor XII and integrin αIIbβ3

ISTH Academy, Faculty / Presenters, 401394

HTRS2023.P1.3 HMGB1 contributes to platelet activation in sickle cell disease through enhancement of purinergic signaling

ISTH Academy, Faculty / Presenters, 401393

HTRS2023.P1.1 Comparison of light transmission and whole blood lumiaggregometry in evaluation of pediatric patients for platelet function disorders

ISTH Academy, Faculty / Presenters, 401392

HTRS2023.O8C.4 Subject with infertility due to congenital plasminogen deficiency type 1: results of plasminogen replacement therapy and impact of varying dosage regimen during treatment and maintenance phases

ISTH Academy, Faculty / Presenters, 401391

HTRS2023.O8C.2 Eptacog beta efficacy and safety in underweight, normal weight, and overweight/obese persons with hemophilia A or B and inhibitors

ISTH Academy, Faculty / Presenters, 401390

Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT

ISTH Academy, Ishac Nazy, 394010

HTRS2023.P2.1 Will my patient bleed? Management and outcomes for patients with severe FXI deficiency

ISTH Academy, Faculty / Presenters, 401397